Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors
Tobacco use remains the leading cause of preventable death, causing over 400,000 annual deaths in the United States alone. Smartphone-based interventions, particularly those levera...
Connect directly with recruiting clinical studies, NCI cancer centers, and research programs across America.
Tobacco use remains the leading cause of preventable death, causing over 400,000 annual deaths in the United States alone. Smartphone-based interventions, particularly those levera...
This study is open to adults with diabetic macular edema that involves the center of the eye. The purpose of this study is to find out how well different doses of a medicine called...
Hispanic adolescents in the U.S. are disproportionately burdened by type 2 diabetes (T2D) compared to non-Hispanic white youth (0.079% vs. 0.017%) contributing to higher rates of T...
This clinical trial evaluates an educational program called Algorithm-Enabled Patients Activated in Cancer Care Through Teams (A-PACT) for reducing unplanned hospital visits and im...
The overarching goal of the Kentucky LEADS Collaborative Lung Cancer Survivorship Care program is to reduce the burden of lung cancer by offering an innovative survivorship care ap...
The overall goal is to investigate the effectiveness of a novel intervention - Breathing-controlled electrical stimulation (BreEStim) on finger flexor spasticity reduction and hand...
The primary endpoint is to determine if ECP induces a decrease in % of tumor cells after treatment. 20 patients with Sezary Syndrome will receive ECP weekly x4, then bi-weekly for ...
Thresholds In food allergy evaluaTion And predictioN, a prospective, observational registry. The aim is to quantify food allergy thresholds in Canada and their clinical predictors....
Pregnancy elicits adaptive changes in uteroplacental blood flow, which are altered at high altitude and may contribute to the observed 3-fold increase in intrauterine growth restri...
This study will address the question of whether targeting CMV antigens with PEP-CMV can serve as a novel immunotherapeutic approach in pediatric patients with newly-diagnosed high-...
Select your broad health category and distance preferences to pinpoint eligible open trials.
Browse research protocols categorized by primary disease domain.
Targeted biologics, immunotherapies, and CAR-T trials.
Alzheimer's, dementia, and neurological research.
Hypertension, heart failure, and coronary artery studies.
Glucose monitoring, insulin therapies, and metabolic health.
Rheumatoid arthritis, Crohn's, and immunology protocols.
Orphan designations and gene therapy trials.
Phase 1 safety studies and healthy comparator protocols.
COPD, respiratory treatments, and inhaler evaluations.
Direct clinical intake phone hotlines and specialized trial departments.
Houston, Texas • Intake: (877) 632-6789
View Center ProfileNew York, New York • Intake: (800) 525-2225
View Center ProfileRochester, MN & Phoenix, AZ • Intake: (800) 664-4580
View Center ProfileBoston, Massachusetts • Intake: (877) 338-7425
View Center Profile